Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

19/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
16/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI

Market Cap	2.71M 2.37M 2.17M 2.03M 3.85M 258M 3.9M 26.11M 10.15M 127M 10.16M 9.94M 437M	P/E 2022	-0.25x	P/E 2023	-0.19x
Enterprise Value	12.83M 11.21M 10.31M 9.61M 18.22M 1.22B 18.5M 124M 48.09M 600M 48.15M 47.11M 2.07B	EV / Sales 2022	1.19x	EV / Sales 2023	1.78x
Free-Float	88.44%	Yield 2022 *	-	Yield 2023	-

19/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
16/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI
10/02/25	Avinger Inc Terminated Employment Of Each Of Jeffrey M. Soinski, Co's CEO And Nabeel Subainati, Vice President, Finance	RE
10/02/25	Avinger, Inc. Announces Termination of the Employment of Jeffrey M. Soinski, Chief Executive Officer	CI
10/02/25	Avinger, Inc. Announces Executive Changes	CI
24/12/24	Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break	MT
24/12/24	US Futures Tread Water Ahead of Holiday Break	MT
23/12/24	Iberdrola Completes Merger with Avangrid	MT
07/11/24	Avinger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
07/11/24	Earnings Flash (AVGR) AVINGER Reports Q3 Loss $-1.82	MT
07/11/24	Earnings Flash (AVGR) AVINGER Posts Q3 Revenue $1.7M	MT
07/11/24	Avinger, Inc., Q3 2024 Earnings Call, Nov 07, 2024
04/10/24	Wall Street Set to Open Higher Friday on Strong Employment Data	MT

21/04/23	HC Wainwright Starts Avinger at Buy With $1.60 Price Target	MT
11/05/22	B. Riley Lowers Avinger's Price Target to $9 from $11, Keeps Buy Rating	MT
18/03/22	B. Riley Adjusts Avinger's Price Target to Post-Split $11 from $40, Expects Omicron Impact Late in Q4, Into Q1; Keeps Buy Rating	MT
29/06/21	AVINGER : B. Riley Starts Avinger at Buy with $2.50 PT, Says Well-Positioned to Execute on Growth Strategy	MT

02/01/25	Avinger : Private Placement Form 8 K	PU
08/11/24	Avinger : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)	PU
08/11/24	Avinger : Reports Third Quarter 2024 Results Form 8 K	PU
07/11/24	Avinger: Q3 Earnings Snapshot	AQ
25/10/24	Avinger Releases Updated Data from IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention	AQ

AVINGER Share Price Nasdaq

Stocks

Advanced Medical Equipment & Technology

Valuation: AVINGER

Latest news : AVINGER

Analysts' recommendations: AVINGER

Press Releases: AVINGER

Managers and Directors: AVINGER

Medical Imaging Systems

Financials

Company Profile

Manager	Title	Age	Since
Karina Yamamoto CEO	Chief Executive Officer	-	-
Thomas Davis CTO	Chief Tech/Sci/R&D Officer	-	04/08/2024

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	+1.01%	+6.82%	-17.00%	-25.04%	12.68B
IRAY GROUP	-0.64%	+12.90%	+96.73%	+14.47%	5.2B
IRADIMED CORPORATION	+2.99%	+7.46%	+63.38%	+110.88%	1.29B
SONOSCAPE MEDICAL CORP.	+1.56%	+8.79%	-31.06%	-63.11%	1.24B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	+0.09%	+7.43%	-37.06%	-47.02%	1.12B
SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENT CO., LTD.	+2.72%	+6.36%	-43.18%	-	928M
CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD.	-1.88%	+5.93%	+166.25%	+151.12%	637M
CAPSOVISION, INC.	-1.22%	-3.19%	+65.45%	-	364M
FISCHER MEDICAL VENTURES LIMITED	+0.59%	+5.96%	-52.58%	+227.58%	268M
Average	+0.58%	+4.01%	+23.44%	+52.70%	2.64B
Weighted average by Cap.	+0.69%	+4.05%	+15.36%	-3.26%

	2022	2023
Net sales	8.27M 7.23M 6.65M 6.2M 11.75M 788M 11.93M 79.79M 31.02M 387M 31.05M 30.39M 1.33B	7.65M 6.69M 6.15M 5.73M 10.87M 729M 11.03M 73.8M 28.69M 358M 28.72M 28.11M 1.23B
Net income	-17.62M -15.41M -14.16M -13.2M -25.03M -1.68B -25.41M -170M -66.08M -825M -66.15M -64.73M -2.84B	-18.32M -16.02M -14.72M -13.72M -26.02M -1.74B -26.42M -177M -68.69M -857M -68.77M -67.29M -2.95B
Net Debt	1.76M 1.54M 1.41M 1.31M 2.49M 167M 2.53M 16.94M 6.58M 82.19M 6.59M 6.45M 283M	10.12M 8.85M 8.13M 7.58M 14.37M 964M 14.59M 97.61M 37.94M 474M 37.99M 37.17M 1.63B

End-of-day quote Nasdaq Other stock markets
- ^USD	-